Cargando…

Diffusion-Weighted Magnetic Resonance Imaging for Breast Cancer Screening in High-Risk Women: Design and Imaging Protocol of a Prospective Multicenter Study in Korea

PURPOSE: Interest in unenhanced magnetic resonance imaging (MRI) screening for breast cancer is growing due to concerns about gadolinium deposition in the brain and the high cost of contrast-enhanced MRI. The purpose of this report is to describe the protocol of the Diffusion-Weighted Magnetic Reson...

Descripción completa

Detalles Bibliográficos
Autores principales: Shin, Hee Jung, Lee, Su Hyun, Park, Vivian Youngjean, Yoon, Jung Hyun, Kang, Bong Joo, Yun, Bo La, Kim, Tae Hee, Ko, Eun Sook, Han, Boo-Kyung, Chu, A Jung, Park, Seo Young, Kim, Hak Hee, Moon, Woo Kyung
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Breast Cancer Society 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8090809/
https://www.ncbi.nlm.nih.gov/pubmed/33913277
http://dx.doi.org/10.4048/jbc.2021.24.e19
_version_ 1783687372628557824
author Shin, Hee Jung
Lee, Su Hyun
Park, Vivian Youngjean
Yoon, Jung Hyun
Kang, Bong Joo
Yun, Bo La
Kim, Tae Hee
Ko, Eun Sook
Han, Boo-Kyung
Chu, A Jung
Park, Seo Young
Kim, Hak Hee
Moon, Woo Kyung
author_facet Shin, Hee Jung
Lee, Su Hyun
Park, Vivian Youngjean
Yoon, Jung Hyun
Kang, Bong Joo
Yun, Bo La
Kim, Tae Hee
Ko, Eun Sook
Han, Boo-Kyung
Chu, A Jung
Park, Seo Young
Kim, Hak Hee
Moon, Woo Kyung
author_sort Shin, Hee Jung
collection PubMed
description PURPOSE: Interest in unenhanced magnetic resonance imaging (MRI) screening for breast cancer is growing due to concerns about gadolinium deposition in the brain and the high cost of contrast-enhanced MRI. The purpose of this report is to describe the protocol of the Diffusion-Weighted Magnetic Resonance Imaging Screening Trial (DWIST), which is a prospective, multicenter, intraindividual comparative cohort study designed to compare the performance of mammography, ultrasonography, dynamic contrast-enhanced (DCE) MRI, and diffusion-weighted (DW) MRI screening in women at high risk of developing breast cancer. METHODS: A total of 890 women with BRCA mutation or family history of breast cancer and lifetime risk ≥ 20% are enrolled. The participants undergo 2 annual breast screenings with digital mammography, ultrasonography, DCE MRI, and DW MRI at 3.0 T. Images are independently interpreted by trained radiologists. The reference standard is a combination of pathology and 12-month follow-up. Each image modality and their combination will be compared in terms of sensitivity, specificity, accuracy, positive predictive value, rate of invasive cancer detection, abnormal interpretation rate, and characteristics of detected cancers. The first participant was enrolled in April 2019. At the time of manuscript submission, 5 academic medical centers in South Korea are actively enrolling eligible women and a total of 235 women have undergone the first round of screening. Completion of enrollment is expected in 2022 and the results of the study are expected to be published in 2026. DISCUSSION: DWIST is the first prospective multicenter study to compare the performance of DW MRI and conventional imaging modalities for breast cancer screening in high-risk women. DWIST is currently in the patient enrollment phase. TRIAL REGISTRATION: ClinicalTrials.gov Identifier: NCT03835897
format Online
Article
Text
id pubmed-8090809
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Korean Breast Cancer Society
record_format MEDLINE/PubMed
spelling pubmed-80908092021-05-11 Diffusion-Weighted Magnetic Resonance Imaging for Breast Cancer Screening in High-Risk Women: Design and Imaging Protocol of a Prospective Multicenter Study in Korea Shin, Hee Jung Lee, Su Hyun Park, Vivian Youngjean Yoon, Jung Hyun Kang, Bong Joo Yun, Bo La Kim, Tae Hee Ko, Eun Sook Han, Boo-Kyung Chu, A Jung Park, Seo Young Kim, Hak Hee Moon, Woo Kyung J Breast Cancer Study Protocol PURPOSE: Interest in unenhanced magnetic resonance imaging (MRI) screening for breast cancer is growing due to concerns about gadolinium deposition in the brain and the high cost of contrast-enhanced MRI. The purpose of this report is to describe the protocol of the Diffusion-Weighted Magnetic Resonance Imaging Screening Trial (DWIST), which is a prospective, multicenter, intraindividual comparative cohort study designed to compare the performance of mammography, ultrasonography, dynamic contrast-enhanced (DCE) MRI, and diffusion-weighted (DW) MRI screening in women at high risk of developing breast cancer. METHODS: A total of 890 women with BRCA mutation or family history of breast cancer and lifetime risk ≥ 20% are enrolled. The participants undergo 2 annual breast screenings with digital mammography, ultrasonography, DCE MRI, and DW MRI at 3.0 T. Images are independently interpreted by trained radiologists. The reference standard is a combination of pathology and 12-month follow-up. Each image modality and their combination will be compared in terms of sensitivity, specificity, accuracy, positive predictive value, rate of invasive cancer detection, abnormal interpretation rate, and characteristics of detected cancers. The first participant was enrolled in April 2019. At the time of manuscript submission, 5 academic medical centers in South Korea are actively enrolling eligible women and a total of 235 women have undergone the first round of screening. Completion of enrollment is expected in 2022 and the results of the study are expected to be published in 2026. DISCUSSION: DWIST is the first prospective multicenter study to compare the performance of DW MRI and conventional imaging modalities for breast cancer screening in high-risk women. DWIST is currently in the patient enrollment phase. TRIAL REGISTRATION: ClinicalTrials.gov Identifier: NCT03835897 Korean Breast Cancer Society 2021-04-09 /pmc/articles/PMC8090809/ /pubmed/33913277 http://dx.doi.org/10.4048/jbc.2021.24.e19 Text en © 2021 Korean Breast Cancer Society https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (https://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Study Protocol
Shin, Hee Jung
Lee, Su Hyun
Park, Vivian Youngjean
Yoon, Jung Hyun
Kang, Bong Joo
Yun, Bo La
Kim, Tae Hee
Ko, Eun Sook
Han, Boo-Kyung
Chu, A Jung
Park, Seo Young
Kim, Hak Hee
Moon, Woo Kyung
Diffusion-Weighted Magnetic Resonance Imaging for Breast Cancer Screening in High-Risk Women: Design and Imaging Protocol of a Prospective Multicenter Study in Korea
title Diffusion-Weighted Magnetic Resonance Imaging for Breast Cancer Screening in High-Risk Women: Design and Imaging Protocol of a Prospective Multicenter Study in Korea
title_full Diffusion-Weighted Magnetic Resonance Imaging for Breast Cancer Screening in High-Risk Women: Design and Imaging Protocol of a Prospective Multicenter Study in Korea
title_fullStr Diffusion-Weighted Magnetic Resonance Imaging for Breast Cancer Screening in High-Risk Women: Design and Imaging Protocol of a Prospective Multicenter Study in Korea
title_full_unstemmed Diffusion-Weighted Magnetic Resonance Imaging for Breast Cancer Screening in High-Risk Women: Design and Imaging Protocol of a Prospective Multicenter Study in Korea
title_short Diffusion-Weighted Magnetic Resonance Imaging for Breast Cancer Screening in High-Risk Women: Design and Imaging Protocol of a Prospective Multicenter Study in Korea
title_sort diffusion-weighted magnetic resonance imaging for breast cancer screening in high-risk women: design and imaging protocol of a prospective multicenter study in korea
topic Study Protocol
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8090809/
https://www.ncbi.nlm.nih.gov/pubmed/33913277
http://dx.doi.org/10.4048/jbc.2021.24.e19
work_keys_str_mv AT shinheejung diffusionweightedmagneticresonanceimagingforbreastcancerscreeninginhighriskwomendesignandimagingprotocolofaprospectivemulticenterstudyinkorea
AT leesuhyun diffusionweightedmagneticresonanceimagingforbreastcancerscreeninginhighriskwomendesignandimagingprotocolofaprospectivemulticenterstudyinkorea
AT parkvivianyoungjean diffusionweightedmagneticresonanceimagingforbreastcancerscreeninginhighriskwomendesignandimagingprotocolofaprospectivemulticenterstudyinkorea
AT yoonjunghyun diffusionweightedmagneticresonanceimagingforbreastcancerscreeninginhighriskwomendesignandimagingprotocolofaprospectivemulticenterstudyinkorea
AT kangbongjoo diffusionweightedmagneticresonanceimagingforbreastcancerscreeninginhighriskwomendesignandimagingprotocolofaprospectivemulticenterstudyinkorea
AT yunbola diffusionweightedmagneticresonanceimagingforbreastcancerscreeninginhighriskwomendesignandimagingprotocolofaprospectivemulticenterstudyinkorea
AT kimtaehee diffusionweightedmagneticresonanceimagingforbreastcancerscreeninginhighriskwomendesignandimagingprotocolofaprospectivemulticenterstudyinkorea
AT koeunsook diffusionweightedmagneticresonanceimagingforbreastcancerscreeninginhighriskwomendesignandimagingprotocolofaprospectivemulticenterstudyinkorea
AT hanbookyung diffusionweightedmagneticresonanceimagingforbreastcancerscreeninginhighriskwomendesignandimagingprotocolofaprospectivemulticenterstudyinkorea
AT chuajung diffusionweightedmagneticresonanceimagingforbreastcancerscreeninginhighriskwomendesignandimagingprotocolofaprospectivemulticenterstudyinkorea
AT parkseoyoung diffusionweightedmagneticresonanceimagingforbreastcancerscreeninginhighriskwomendesignandimagingprotocolofaprospectivemulticenterstudyinkorea
AT kimhakhee diffusionweightedmagneticresonanceimagingforbreastcancerscreeninginhighriskwomendesignandimagingprotocolofaprospectivemulticenterstudyinkorea
AT moonwookyung diffusionweightedmagneticresonanceimagingforbreastcancerscreeninginhighriskwomendesignandimagingprotocolofaprospectivemulticenterstudyinkorea